© Grace Therapeutics, Inc. All Rights Reserved.

May 7, 2021

Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc.

Grace provides Acasti with a pipeline of rare and orphan disease programs, including 3 clinical stage assets that have received Orphan Drug Designation from the FDA

Read More
June 12, 2019

Grace Therapeutics to Present at the Raymond James Life Sciences and MedTech Conference

Grace’s presentation is scheduled for Tuesday, June 18, 2019 at 9:10 a.m. Eastern Time in the Kennedy II Room at the Lotte New York Palace.

Read More
May 29, 2019

Grace Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference

Grace’s presentation is scheduled for Tuesday, June 4, 2019 at 11:30 a.m. Eastern Time at the Grand Hyatt, New York.

Read More
February 21, 2019

Grace Therapeutics to Present at the Cowen 39th Annual Healthcare Conference

Presentation is scheduled for Monday, March 11, 2019 at 4.00 p.m. Eastern Time.

Read More
January 2, 2019

Grace Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Presentation is scheduled for Thursday, January 10, 2019 at 9.00 a.m. Pacific Time.

Read More
September 7, 2018

Grace Therapeutics to Present at the Morgan Stanley Global Healthcare Conference

Dr. Bruce Hochstadt, COO, and Prashant Kohli, Head of Commercialization, will discuss the company’s vision, pipeline, and commercial strategy for accelerated value creation.

Read More
July 10, 2018

Hon. Robert Hormats Joins Grace Therapeutics’ Board of Directors

Widely respected Diplomat and Wall Street Executive will serve on Grace’s Board

Read More
June 22, 2018

William A. Haseltine, PhD Joins Grace Therapeutics’ Board of Directors

Pioneering Scientist and Former CEO of Human Genome Sciences Brings Key Expertise to Grace’s Board

Read More